{"name":"MRM Health NV","slug":"mrm-health-nv","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Low-dose MH002","genericName":"Low-dose MH002","slug":"low-dose-mh002","indication":"Type 2 diabetes","status":"phase_2"}]}],"pipeline":[{"name":"Low-dose MH002","genericName":"Low-dose MH002","slug":"low-dose-mh002","phase":"phase_2","mechanism":"Low-dose MH002 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes","Heart failure"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxOY25qWk85RVFIVGlLdllmX1dKdmlGa1BWaHQwTDRPUm1vQ09mVXJDQ0FLMXpHcEJ0X3FhdXo5TkxDLWtsS2FGaWdVZ1B6dC1mXzZvZ3psVVNnY09obmtHaHhzM1F2MTFRVXJrOG1Zc0tsZXM1dkhOckRNMkpfZFFwRFk3QUJBbzFvazNXOHFDb1RoQ0Z5RHZsVkJvR0J1OGpULVNrOE5qNVhUeG9ab3Q5b1JQblJMclM0dkEyTVRLWmhhVTNxTlI5cUl0MkFUMFZlNld2aTMwQ190MlVKV0l3VDFMSnA5UlJxYk9UWjk2RDNPWEtEcjRpelBOdVV3MGc?oc=5","date":"2026-01-09","type":"regulatory","source":"businesswire.com","summary":"MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis - businesswire.com","headline":"MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiT0FVX3lxTFBxYVVjZlZKR0RvTWVXZk5hZG1pZldtY255cW5oTHFvVmNKVi1oelFLVTRkMHl2dUdZMHJBWlFHMGVjV3lIQUNpT0RRZWJmbUU?oc=5","date":"2025-12-16","type":"pipeline","source":"Failory","summary":"Top 55 Ghent Startups to Watch in 2026 - Failory","headline":"Top 55 Ghent Startups to Watch in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE5QMlFfTHFPWTZhVWI2NnFfTktLc25pR2ZLZTk3WUx3cjh0dERzU2YxM2JIRWt0Y0I3eS1xalNXUEh2NWR4aXMzQjF2b3BUQ2lsQWhPZDJSdUlqRTg?oc=5","date":"2025-11-21","type":"pipeline","source":"Failory","summary":"Top 100 Pharmaceutical Startups to Watch in 2026 - Failory","headline":"Top 100 Pharmaceutical Startups to Watch in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPd3AxNUxra3FrV0gyRE9ZUlc2OFhfbzdfQ3o4dE1pY2otcTRoOVRTLUtCNUFkb1dzWE1tWTZwVmhSeWlzMThtRHdKbXIwSXRSQ0ZyTVRwajRsUWhHejB0X2U2dlNxNDFmdmFLcHd4cjFrblRrb0x0Sy1VRGd0VEtqN1BvUU1WTC1xQ2pXa0VDdjlhcE85QVpfdFBTQ2ZpNkV3WEtBWTJGM2dQTzItRm5jX2pfbnktWUVyVWJlQ05QZm9YcGc?oc=5","date":"2025-09-11","type":"pipeline","source":"SynBioBeta","summary":"MRM Health Secures €55 Million in Series B Financing to Propel Microbiome-Based Therapeutics - SynBioBeta","headline":"MRM Health Secures €55 Million in Series B Financing to Propel Microbiome-Based Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNdXYzUEphbm9RYlhVeS13R0pWNGQzNW1WZFY0a1doRENUdXpHeUNHMWh4SlE4ZURKWVBwUHhUa2R1VTZWVnk1Yk10VFdJYjA2ZkVIb2NUX1BRSXdwNTh6UVhPRmNGRWlHVkc0dmNkb1NlRDhEdHlKTGxQUWpqbHFZM2NWV3kzWVRBd2lTODNBdTA4RFZGck1B?oc=5","date":"2025-09-04","type":"pipeline","source":"Contract Pharma","summary":"MRM Health Closes $64M Series B Financing Round - Contract Pharma","headline":"MRM Health Closes $64M Series B Financing Round","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOdXBWbzNWSWhybEl3dkloWVJPUGRjUjBycXBrbmhnZmtWSWJpSmlrWl9CYUVKUnFPS0ZaTWp2UE1kaVFLbm1HNFlRWHN2VEl1bnB0cmhuaVc3cjIxRUxLb0M1RHF5Tk00Wkx3bTZIVXU0SHhRaXVzU1Q5eEdYRElSbXRzNk5QMWlXWVF6RzAtNXoyYjkzbkY4bFN4UmZOX2Nkd2tr?oc=5","date":"2025-09-04","type":"pipeline","source":"European Biotechnology Magazine","summary":"Microbiome play MRM Health NV raises €55m in Series B - European Biotechnology Magazine","headline":"Microbiome play MRM Health NV raises €55m in Series B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxOVlhSTjlVcnRvLUhMX05MdU9OUkViQ1dEYlZqZHFTc2JjNmhaT29walNqaHVmcEcwdy1NOFVoOXdFSHJIY01UeEFFOVhhakVnWUpOU0hRUEV1ZS1XX0NNQ180OUpEcUg2dkpIcUo3Yldxc0RSTW5ySWFHd2pWbGZFVjRMUHE2Z0Fkb2U3MWwtN0l6SE5PMC05d3gyU3pqYlI1RGY0S1dYaVBIdVBWa0x6V2FiWXVmajJJSUxHUEkzZ0ZlVDl1eDF1a2w3RndlLUxGQlR6TkRDeEMzZERhQU5YRlZJeTZtU3d6bVpVS2pfMVhTT2QwT3NJY1l0RlA4cldrdDRwTFlWMDY?oc=5","date":"2025-09-04","type":"pipeline","source":"businesswire.com","summary":"MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-Based Biotherapeutic Product Pipeline - businesswire.com","headline":"MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-Based Biotherapeutic Product Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxPc2g0N2ZTa0Rsdi1INkNyemthOVlwUExoVTRaamktRWlrdzdfVk9lNUNZaGdldUtpenpiTGZjWDFraUhmcjAzYTNsaTJsVXdaQk1teWtRS3REd2RFdWs4eUJGaXR0VFh1NmdIVzRrUG5HU2JVd3dHTHoyVlV6NzAtenNobXVYd2E3ajRBR01TZGszcV9uVkRfMWEyZU5rQ1MyMWROYTZybml0REZKSDBwRUFCTTgxZU9XX0gyWWdiNXNqQlB3MElSSDR6RktULXduaExaYmxqY0R0RWVtYlpiU3VwWThEYjA?oc=5","date":"2025-09-04","type":"pipeline","source":"businesswire.com","summary":"Biocodex Invests up to €30 Million in MRM Health, a Belgian Microbiome Therapy Innovator - businesswire.com","headline":"Biocodex Invests up to €30 Million in MRM Health, a Belgian Microbiome Therapy Innovator","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPYVhRWk5paERkMG13akl6SFgzOVBFbVg3dVRrbWcwTWhkZ0FqR3FoV2lCTFpEdDdScVFxcGhIbzhIWXhOVFNaWUhoTnBMYXBwcVNubEk5bnVSSDVrRngtbGIyTnhtN1FBNUtKNlJXTXVWeTRGaHJwa2FKZzh4Um9rN1VGNVlVWHZFVmVHRkJkdWtOc3U2VXN6a3JoREdKUUJUMkxjZEdQamJacTN0QkZxLUdtWQ?oc=5","date":"2025-09-04","type":"pipeline","source":"geneonline.com","summary":"Best-in-Class Experimental Gut Bacteria-Based Medicine: MRM Health Lands US$64 Million Series B - geneonline.com","headline":"Best-in-Class Experimental Gut Bacteria-Based Medicine: MRM Health Lands US$64 Million Series B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOM01xOHZkNzVpSy0waVVHNFFiODNKS2hZaktIejFIYWhiTEJVMEUtMGpDRTNaUEFYWndvMGdJdEJrblBVbVpBbU9SNzluSnVMS09OeWxxSnpvT0pkbGxHdlo5SmlzRDVzdDdyUk9zeWFnRHhWeGExQVAxcklSY0hKZ0tGNWgwQzFxMG4wYTdDWDlSVkxhOGVjOGdYQTNGQTBPcXU0?oc=5","date":"2025-09-04","type":"pipeline","source":"BioWorld News","summary":"MRM raises $64M for ‘high performance teams of bacteria' in IBD - BioWorld News","headline":"MRM raises $64M for ‘high performance teams of bacteria' in IBD","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2020-07-28","type":"pipeline","source":"THE STAR - St Lucia","summary":"Belgium-based MRM Health NV appoints Saint Lucian Dr. Nigel Horscroft as Chief Scientific Officer - THE STAR - St Lucia","headline":"Belgium-based MRM Health NV appoints Saint Lucian Dr. Nigel Horscroft as Chief Scientific Officer - THE STAR","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2020-02-20","type":"deal","source":"Express Pharma","summary":"DuPont Nutrition & Biosciences enters into collaboration with microbiome specialist MRM Health - Express Pharma","headline":"DuPont Nutrition & Biosciences enters into collaboration with microbiome specialist MRM Health","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}